| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.3M | — | +96.3% |
| R&D Expense | $46.7M | — | +9.8% |
| SG&A Expense | $12.3M | — | -35.3% |
| Operating Income | -$57.5M | — | +8.2% |
| Pre-tax Income | -$49.5M | — | +6.5% |
| Income Tax | -$6.4M | — | +13.5% |
| Net Income | -$43.2M | — | +5.4% |
| EPS (Basic) | -$0.14 | — | +6.7% |
| EPS (Diluted) | -$0.14 | — | +6.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $77.1M | -40.0% | -51.6% |
| Accounts Receivable | $39.2M | -0.6% | -38.4% |
| Inventory | $7.9M | +24.1% | — |
| Current Assets | $664.6M | -8.7% | -13.1% |
| Total Assets | $1.31B | -3.7% | -2.8% |
| Current Liabilities | $47.3M | -26.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.5M | — | -190.1% |
| Capital Expenditures | $3.8M | — | -64.0% |
| Investing Cash Flow | -$25.1M | — | -416.1% |
| Financing Cash Flow | $7.2M | — | +20.5% |
| Free Cash Flow | -$37.4M | — | -68.3% |
| -37.3% |
| Total Liabilities | $369.0M | -5.4% | +14.9% |
| Stockholders' Equity | $938.1M | -3.0% | -8.3% |